Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study

OBJECTIVES: Alzheimer's disease (AD) is the most common cause of dementia worldwide in the older population. There is no disease-modifying therapy available for AD. The current standard of care drug therapy for AD is cholinesterase inhibitors, including donepezil. Bacopa monnieri or brahmi is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhakar, Sudesh, Vishnu, Venugopalan Y., Modi, Manish, Mohanty, Manju, Sharma, Anchal, Medhi, Bikas, Mittal, BR, Khandelwal, Niranjan, Goyal, Manoj K., Lal, Vivek, Singla, Rajesh, Kansal, Avinash, Avasthi, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900738/
https://www.ncbi.nlm.nih.gov/pubmed/33688125
http://dx.doi.org/10.4103/aian.AIAN_610_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900738/
https://www.ncbi.nlm.nih.gov/pubmed/33688125
http://dx.doi.org/10.4103/aian.AIAN_610_19

Ejemplares similares